Description
A CB1 receptor agonist and PAM; a racemic mixture of GAT228 and GAT229; increases β-arrestin recruitment and cAMP inhibition in HEK293A cells expressing hCB1-GFP in a concentration-dependent manner; enhances the binding of the CB1 full agonist CP 55,940 to CHO cells expressing hCB1; inhibits EPSCs in a subset of CB1-expressing murine autaptic hippocampal neurons at 1 µM; decreases mechanical hypersensitivity in wild-type (EC50 = 9.75 mg/kg), but not CB1 knockout, mice in a model of CFA-induced inflammatory pain; decreases mechanical and cold allodynia in a mouse model of paclitaxel-induced neuropathic pain at 10 and 20 mg/kg per day
Formal name: 3-(2-nitro-1-phenylethyl)-2-phenyl-1H-indole
Synonyms:
Molecular weight: 342.4
CAS: 102704-40-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Product Type|Biochemicals|Receptor Pharmacology|Allosteric Modulators||Research Area|Neuroscience|Cannabinoid Research|CB1 & CB2 Receptors||Research Area|Neuroscience|Pain Research